##gff-version 3
##sequence-region Q07666 1 443
Q07666	UniProtKB	Chain	1	443	.	.	.	ID=PRO_0000050124;Note=KH domain-containing%2C RNA-binding%2C signal transduction-associated protein 1	
Q07666	UniProtKB	Domain	171	197	.	.	.	Note=KH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00117	
Q07666	UniProtKB	Region	100	260	.	.	.	Note=Involved in homodimerization;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:26758068;Dbxref=PMID:26758068	
Q07666	UniProtKB	Region	351	443	.	.	.	Note=Interaction with HNRNPA1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17371836;Dbxref=PMID:17371836	
Q07666	UniProtKB	Region	400	420	.	.	.	Note=Interaction with ZBTB7A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24514149;Dbxref=PMID:24514149	
Q07666	UniProtKB	Compositional bias	34	41	.	.	.	Note=Pro-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Compositional bias	44	55	.	.	.	Note=DMA/Gly-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Compositional bias	59	89	.	.	.	Note=Pro-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Compositional bias	282	292	.	.	.	Note=DMA/Gly-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Compositional bias	295	301	.	.	.	Note=Pro-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Compositional bias	302	332	.	.	.	Note=Arg/Gly-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Compositional bias	334	363	.	.	.	Note=Pro-rich;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q07666	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q07666	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q07666	UniProtKB	Modified residue	29	29	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q07666	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q07666	UniProtKB	Modified residue	45	45	.	.	.	Note=Asymmetric dimethylarginine%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	52	52	.	.	.	Note=Asymmetric dimethylarginine%3B partial%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	58	58	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:24275569;Dbxref=PMID:18691976,PMID:24275569	
Q07666	UniProtKB	Modified residue	84	84	.	.	.	Note=Phosphothreonine%3B by MAPK1;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q60749	
Q07666	UniProtKB	Modified residue	113	113	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q60749	
Q07666	UniProtKB	Modified residue	150	150	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q07666	UniProtKB	Modified residue	175	175	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q07666	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q07666	UniProtKB	Modified residue	282	282	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q07666	UniProtKB	Modified residue	284	284	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q07666	UniProtKB	Modified residue	291	291	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q60749	
Q07666	UniProtKB	Modified residue	304	304	.	.	.	Note=Asymmetric dimethylarginine%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	310	310	.	.	.	Note=Omega-N-methylarginine%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	315	315	.	.	.	Note=Omega-N-methylarginine%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	320	320	.	.	.	Note=Dimethylated arginine%3B in A2780 ovarian carcinoma cell line;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7	
Q07666	UniProtKB	Modified residue	320	320	.	.	.	Note=Omega-N-methylarginine%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	325	325	.	.	.	Note=Omega-N-methylarginine%3B by PRMT1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12529443;Dbxref=PMID:12529443	
Q07666	UniProtKB	Modified residue	331	331	.	.	.	Note=Asymmetric dimethylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q60749	
Q07666	UniProtKB	Modified residue	331	331	.	.	.	Note=Dimethylated arginine%3B in A2780 ovarian carcinoma cell line;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7	
Q07666	UniProtKB	Modified residue	331	331	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q07666	UniProtKB	Modified residue	331	331	.	.	.	Note=Omega-N-methylated arginine%3B by PRMT1%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7	
Q07666	UniProtKB	Modified residue	340	340	.	.	.	Note=Dimethylated arginine%3B in A2780 ovarian carcinoma cell line;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.7	
Q07666	UniProtKB	Modified residue	340	340	.	.	.	Note=Omega-N-methylarginine%3B by PRMT1;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:15782174,ECO:0000244|PubMed:24129315;Dbxref=PMID:15782174,PMID:24129315	
Q07666	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:22000517;Dbxref=PMID:22000517	
Q07666	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q07666	UniProtKB	Modified residue	435	435	.	.	.	Note=Phosphotyrosine%3B by PTK6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16179349;Dbxref=PMID:16179349	
Q07666	UniProtKB	Modified residue	440	440	.	.	.	Note=Phosphotyrosine%3B by PTK6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16179349;Dbxref=PMID:16179349	
Q07666	UniProtKB	Modified residue	443	443	.	.	.	Note=Phosphotyrosine%3B by PTK6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16179349;Dbxref=PMID:16179349	
Q07666	UniProtKB	Cross-link	96	96	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q07666	UniProtKB	Cross-link	102	102	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q07666	UniProtKB	Cross-link	139	139	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q07666	UniProtKB	Cross-link	175	175	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q07666	UniProtKB	Cross-link	432	432	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q07666	UniProtKB	Alternative sequence	37	61	.	.	.	ID=VSP_051719;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q07666	UniProtKB	Alternative sequence	169	207	.	.	.	ID=VSP_051720;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9013542;Dbxref=PMID:9013542	
Q07666	UniProtKB	Mutagenesis	103	103	.	.	.	Note=Impairs homodimerization. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20610388;Dbxref=PMID:20610388	
Q07666	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Impairs homodimerization. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20610388;Dbxref=PMID:20610388	
Q07666	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Disrupts homodimerization%2C impairs influence on alternative splicing. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20610388;Dbxref=PMID:20610388	
Q07666	UniProtKB	Mutagenesis	229	229	.	.	.	Note=Disrupts binding to poly(A). Decreased binding to the BCL2L1 mRNA. Loss of function in BCL2L1 splicing. Changed nuclear localization. V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17371836;Dbxref=PMID:17371836	
Q07666	UniProtKB	Mutagenesis	241	241	.	.	.	Note=Fails to influence alternative splicing of CD44%2C NRXN2 and NRXN3. Y->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26758068;Dbxref=PMID:26758068	
Q07666	UniProtKB	Mutagenesis	381	381	.	.	.	Note=Disrupts interaction with APC. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22000517;Dbxref=PMID:22000517	
Q07666	UniProtKB	Mutagenesis	383	383	.	.	.	Note=Impairs interaction with APC. Y->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22000517;Dbxref=PMID:22000517	
Q07666	UniProtKB	Mutagenesis	384	384	.	.	.	Note=Disrupts interaction with APC. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22000517;Dbxref=PMID:22000517	
Q07666	UniProtKB	Mutagenesis	435	435	.	.	.	Note=No effect on the nuclear localization. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16179349;Dbxref=PMID:16179349	
Q07666	UniProtKB	Mutagenesis	440	440	.	.	.	Note=Completely blocks nuclear localization. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16179349;Dbxref=PMID:16179349	
Q07666	UniProtKB	Mutagenesis	443	443	.	.	.	Note=No effect on the nuclear localization. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16179349;Dbxref=PMID:16179349	
Q07666	UniProtKB	Helix	100	113	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2XA6	
Q07666	UniProtKB	Helix	119	134	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2XA6	
